Mind Medicine (MNMD) Tops Q3 EPS by 1c

Mind Medicine (NASDAQ: MNMD) reported Q3 EPS of ($0.27), $0.01 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
• UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
• Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell